(Press-News.org) A new study reveals that the US has experienced widespread adoption of robot-assisted prostate removal surgery to treat prostate cancer in recent years. The BJU International study also found that while such surgeries are more expensive than traditional surgeries, their costs are decreasing over time.
In 2001, surgeons began using robotic technologies in operations to remove the prostate. To examine trends in the use of such robotic-assisted radical prostatectomy (RARP) procedures for prostate cancer patients, Steven Chang, MD, MS, of Harvard Medical School, the Dana-Farber Cancer Institute, and Brigham and Women's Hospital, led a team that analyzed 489,369 men who underwent non-RARP (i.e., open or laparoscopic radical prostatectomy) or RARP in the United States from 2003 to 2010.
During the study period, RARP adoption (defined as performing more than 50 percent of annual radical prostatectomies with the robotic approach) increased from 0.7 percent to 42 percent of surgeons performing radical prostatectomies. Surgeons who performed at least 25 radical prostatectomies each year were more likely to adopt RARP. Also, from 2005 to 2007, adoption was more common among surgeons at teaching hospitals and at intermediate and large-sized hospitals. After 2007, adoption was more common among surgeons at urban hospitals. RARP was more costly, disproportionally contributing to the 40 percent increase in annual prostate cancer surgery expenditures; however, RARP costs generally decreased and plateaued at slightly over $10,000 while non-RARP costs increased to nearly $9,000 by the end of the study.
"Our findings give insights on the adoption of not just robotic technology but future surgical innovations in terms of the general pattern of early diffusion, the potential impact on costs of new and competing treatments, and the alternations in practices patterns such as centralization of care to higher volume providers," said Dr. Chang.
INFORMATION: END
US has seen widespread adoption of robot-assisted cancer surgery to remove the prostate
2014-08-26
ELSE PRESS RELEASES FROM THIS DATE:
Common European MRSA originated in Africa
2014-08-26
The predominant strain of community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) infecting people in Europe, the Middle East and northern Africa derived from a single sub-Saharan ancestor, a team of international researchers reported this week in mBio®, the online open-access journal of the American Society for Microbiology.
CA-MRSA refers to MRSA infections occurring in healthy people with no recent hospitalizations. The infections, which are typically skin infections, can be transmitted through close person-to-person contact or contact with a contaminated ...
WSU flu outbreak provides rare study material
2014-08-26
PULLMAN, Wash.—Five years ago this month, one of the first U.S. outbreaks of the H1N1 virus swept through the Washington State University campus, striking some 2,000 people. A university math and biology professor has used a trove of data gathered at the time to gain insight into how only a few infected people could launch the virus's rapid spread across the university community.
The fall 2009 semester hadn't even started when the first cases came in to the university's Health and Wellness Services clinic—11 one day, and just two days later, 47. Not two weeks later, doctors ...
Cancer leaves a common fingerprint on DNA
2014-08-26
Regardless of their stage or type, cancers appear to share a telltale signature of widespread changes to the so-called epigenome, according to a team of researchers. In a study published online in Genome Medicine on Aug. 26, the investigators say they have found widespread and distinctive changes in a broad variety of cancers to chemical marks known as methyl groups attached to DNA, which help govern whether genes are turned "on" or "off," and ultimately how the cell behaves. Such reversible chemical marks on DNA are known as epigenetic, and together they make up the epigenome.
"Regardless ...
RNA sequence could help doctors to tailor unique prostate cancer treatment programs
2014-08-26
Sequencing RNA, not just DNA, could help doctors predict how prostate cancer tumors will respond to treatment, according to research published in the open access journal Genome Biology. Because a tumor's RNA shows the real time changes a treatment is causing, the authors think this could be a useful tool to aid diagnosis and predict which treatment will most benefit individual cancer patients.
Colin Collins and Alexander Wyatt, and other researchers from the Vancouver Prostate Centre at the Vancouver Coastal Health Research Institute, matched 25 patients' treatment outcomes ...
Ever growing number of women with gestational diabetes suggests future will be filled with children with early diabetes
2014-08-26
New research published in Diabetologia (the journal of the European Association for the Study of Diabetes) shows that children exposed to gestational diabetes in the wombs of their mothers are themselves around six times more likely to develop diabetes or prediabetes than children not exposed. The research is by Dr Sonia Caprio, Yale University School of Medicine, New Haven, CT, USA, and colleagues.
With the increase in gestational diabetes (GDM), there is a growing need to understand the effects of glucose exposure on the newborn in the womb, at birth and later in life. ...
Annals of Internal Medicine tip sheet for Aug. 26, 2014
2014-08-26
1. Task Force recommends intensive behavioral counseling for overweight and obese patients with cardio risk factors
Free content
The United States Preventive Services Task Force (USPSTF) recommends that overweight or obese adults with at least one additional risk factor for cardiovascular disease (CVD) be offered or referred to intensive behavioral counseling interventions to promote a healthful diet and physical activity for CVD prevention. The recommendation is being published in Annals of Internal Medicine. Cardiovascular disease is the leading cause of death in ...
Aspirin may reduce the risks of reoccurring blood clots
2014-08-25
Aspirin may be a promising alternative for those who can't take long-term anticoagulant drugs that prevent clots from reoccurring in the veins, according to new research in the American Heart Association journal Circulation.
In a combined analysis of two similar independent studies, 1,224 patients who received 100 mg of aspirin a day to treat blood clots were monitored for at least two years. In the International Collaboration of Aspirin Trials for Recurrent Venous Thromboembolism or INSPIRE analysis, researchers found that aspirin reduced the risk of recurring blood clots ...
Sleep drunkenness disorder may affect 1 in 7
2014-08-25
MINNEAPOLIS – A study is shining new light on a sleep disorder called "sleep drunkenness." The disorder may be as prevalent as affecting one in every seven people. The research is published in the August 26, 2014, print issue of Neurology®, the medical journal of the American Academy of Neurology.
Sleep drunkenness disorder involves confusion or inappropriate behavior, such as answering the phone instead of turning off the alarm, during or following arousals from sleep, either during the first part of the night or in the morning. An episode, often triggered by a forced ...
State medical marijuana laws linked to lower prescription overdose deaths
2014-08-25
In states where it is legal to use medical marijuana to manage chronic pain and other conditions, the annual number of deaths from prescription drug overdose is 25 percent lower than in states where medical marijuana remains illegal, new research suggests.
The findings of the study, led by researchers from the Johns Hopkins Bloomberg School of Public Health and the Philadelphia Veterans Affairs Medical Center, suggest that while medical marijuana laws can be controversial and opponents have raised concerns that they may promote cannabis use among children, they may have ...
Aspirin cuts risk of clots, DVT by a third -- new study
2014-08-25
Low dose aspirin lowers the occurrence of new venous blood clots – and represents a reasonable treatment option for patients who are not candidates for long-term anticoagulant drugs, such as warfarin, according to a new study published in today's issue of Circulation.
"The study provides clear, consistent evidence that low-dose aspirin can help to prevent new venous blood clots and other cardiovascular events among people who are at risk because they have already suffered a blood clot," says the study's lead author, University of Sydney Professor, John Simes.
"The treatment ...